未登录 分享 收藏
A phase 3b trial of gefapixant, a P2X3-receptor antagonist, in women with chronic cough and stress urinary incontinence Birring, S. S.; Cardozo, L.; Dicpinigaitis, P.; Dmochowski, R.; Afzal, A. S.; La Rosa, C.; Lu, S.; Nguyen, A. Martin; Yao, R.; Reyfman, P. 分享 收藏
分享 收藏
RFC1 DISORDER; A GENETIC, NEUROPATHIC CAUSE OF CHRONIC COUGH Hirons, B.; Rhatigan, K.; Curro, R.; Rugginini, B.; Shaw, J.; Abubakar-Waziri, H.; Kesavan, H.; Hadden, R. D. M.; Jolley, C.; Hull, J.; Cho, P. S. P.; Cortese, A.; Birring, S. S. 分享 收藏
Gefapixant efficacy and safety in participants with history of refractory or unexplained chronic cough for ≥1 vs <1 year Smith, J. A.; Satia, I; Birring, S. S.; McGarvey, L.; Lu, S.; Nguyen, A. Martin; Xu, J.; Reyfman, P.; Urdaneta, E.; Philip, G.; La Rosa, C. 分享 收藏
分享 收藏
STAFF EXPERIENCE OF ROUTINE BREATHLESSNESS ASSESSMENT ON A VIRTUAL COVID WARD Rhatigan, K.; Koulopoulou, M.; Fenton, J.; Ramos-Smyth, S.; Ford-Adams, M.; Patel, A.; Cho, P. S. P.; Patel, I.; Birring, S. S.; Jolley, C. J. 分享 收藏
PATIENT-REPORTED IMPROVEMENTS WITH GEFAPIXANT, A P2X3-RECEPTOR ANTAGONIST, OVER 52 WEEKS IN TWO PHASE 3 CLINICAL TRIALS FOR REFRACTORY OR UNEXPLAINED CHRONIC COUGH Birring, S. S.; Dicpinigaitis, P.; Morice, A.; Smith, J. A.; McGarvey, L.; Pavord, I.; Nguyen, A. Martin; Schelfhout, J.; Tzontcheva, A.; Li, Q.; La Rosa, C.; Muccino, D. 分享 收藏
POOLED ANALYSIS OF OBJECTIVE COUGH FREQUENCY IN PARTICIPANTS WITH CHRONIC COUGH TREATED WITH GEFAPIXANT IN TWO PHASE 3 CLINICAL TRIALS (COUGH-1 AND COUGH-2) Smith, J. A.; Morice, A.; McGarvey, L.; Pavord, I.; Birring, S. S.; Dicpinigaitis, P.; Iskold, B.; Li, Q.; Tzontcheva, A.; La Rosa, C.; Muccino, D. 分享 收藏
BASELINE CHARACTERISTICS AND MEDICAL HISTORY OF PATIENTS WITH REFRACTORY OR UNEXPLAINED CHRONIC COUGH PARTICIPATING IN TWO GLOBAL PHASE 3 CLINICAL TRIALS McGarvey, L.; Birring, S. S.; Dicpinigaitis, P.; Morice, A.; Pavord, I.; Smith, J. A.; Iskold, B.; Li, Q.; Nguyen, A. Martin; Schelfhout, J.; Tzontcheva, A.; La Rosa, C.; Muccino, D. 分享 收藏
THE RELATIONSHIP BETWEEN SYMPTOMS AND FUNCTIONAL PHYSIOLOGICAL OUTCOMES IN SURVIVORS OF SEVERE COVID-19 PNEUMONIA Zamani, P.; Mehrotra, S.; Griffin, D.; D'Cruz, R. F.; Mathew, S.; Byrne, A.; Choudhury, M.; Fleming, T.; Cho, P.; Walder, D.; Madula, R.; Smith, L. J.; Macedo, P.; Norton, S.; Birring, S.; Patel, A.; Patel, I.; Perrin, F.; Waller, M.; Jolley, C. J. 分享 收藏
分享 收藏
CLINICAL, RADIOLOGICAL, FUNCTIONAL AND PSYCHOLOGICAL CHARACTERISTICS OF SEVERE COVID-19 PNEUMONIA SURVIVORS: A PROSPECTIVE OBSERVATIONAL COHORT STUDY D'Cruz, R. F.; Perrin, F.; Waller, M.; Periselneris, J.; Norton, S.; Byrne, A.; Mathew, S.; Choudhury, M.; Smith, L-J; Madula, R.; Patrick, T.; Walder, D.; Lee, K.; McNulty, W.; Macedo, P.; Heitmann, A.; Lyall, R.; Warwick, G.; Galloway, J.; Birring, S.; Patel, A.; Patel, I.; Jolley, C. J. 分享 收藏
BENEFITS OBSERVED WITH PATIENT-REPORTED OUTCOMES IN A PHASE 2B CLINICAL TRIAL OF GEFAPIXANT, A P2X3 RECEPTOR ANTAGONIST, IN CHRONIC COUGH Birring, S. S.; McGarvey, L. P.; Smith, J. A.; Morice, A. H.; Sher, M. R.; Schelfhout, J.; Mehta, A.; Muccino, D. R. 分享 收藏
A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMISED, CROSSOVER STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF TRPV4 INHIBITOR GSK2798745 IN PARTICIPANTS WITH CHRONIC COUGH Ludbrook, V. J.; Hanrott, K. E.; Marks-Konczalik, J.; Kreindler, J. L.; Bird, N. P.; Hewens, D.; Beerahee, M.; Behm, D. J.; Morice, A.; McGarvey, L.; Parker, S. M.; Birring, S. S.; Smith, J. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
THE URGE TO COUGH IN COPD Solomon, A.; Cho, P. S. P.; Fletcher, H.; Patel, I. S.; Jolley, C. J.; Turner, R. D.; Birring, S. S. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
未登录.png){kind=icon}